Foreign investment and the export behaviour of foreign and local firms: an analysis of Turkish manufacturing

This paper compares the export performance of a sample of 119 foreign and local firms in Turkey, in 1994 and 1995, using descriptive statistical techniques. It also examines the role of foreign direct investment (FDI) by multinational enterprises (MNEs) in manufacturing exports and its contribution to the changing comparative advantage of Turkish manufacturing sectors. The findings suggest that even after the implementation of liberal economic policies in 1980 foreign and local firms, exporting less than 25% of their output, are principally local market-oriented. The results show, however, that FDI plays an important role in shifting the comparative advantage of manufacturing exports from traditional to technology-intensive sectors. In the long term, this is expected to result in a greater export-orientation for Turkish manufacturing industry.Export Propensity, Foreign Firms, Revealed Comparative Advantage.

The impact of exchange rate volatility on Turkish exports: 1993-2009

This paper attempts to investigate the long-run and short-run relationships between Turkish exports, exchange rate volatility, foreign income, and relative prices by employing quarterly data for the period 1993Q3-2009Q4. Towards this purpose, multivariate cointegration and error correction model (ECM) techniques are used in this study. The long-run estimation results suggest that foreign income and real exchange rate volatility exert positive and statistically significant impacts on Turkish exports, while relative prices affect Turkish exports negatively and significantly. In addition, the results of the ECM model indicate that relative prices have a negative and significant effect, foreign income has an insignificant effect, and nominal exchange rate volatility has a positive and significant effect on Turkish exports

Major Barriers Against Renin-Angiotensin-Aldosterone System Blocker Use in Chronic Kidney Disease Stages 3-5 in Clinical Practice: A Safety Concern?

Renin-angiotensin-aldosterone system (RAAS) blockers are underutilized in patients with chronic kidney disease (CKD). We aimed to determine barriers against the use of RAAS blockers in these patients. Patients with stage 3-5 CKD referred to Hacettepe University Hospital Nephrology Unit during a 1 year period were evaluated for RAAS blocker use. Two hundred and seventy-nine patients (166 male, 113 female) were analyzed. The mean age of the patients was 56.7 +/- 15.2 years, mean serum creatinine was 2.45 +/- 1.44 mg/dL, and mean glomerular filtration rate was 33.3 +/- 15.1 mL/min. The mean follow-up time was 22.0 +/- 21.9 months and the clinical visit number was 4.0 +/- 3.5. Angiotensin-converting-enzyme inhibitors or angiotensin receptor blockers were used by 68.8% of all patients and 67.7% of diabetic patients at the time of analysis. In 82.1% of patients, RAAS blockers had either been used earlier or were being used. Hyperkalemia was the principal reason for both not starting and also discontinuing these drugs in patients with CKD. In 37.4% of patients, reasons for not starting RAAS blockers were unclear. This study showed that hyperkalemia is the major barrier against the use of RAAS blockers in patients with CKD. There was, however, a subset of patients who did not receive RAAS blockers even without clear contraindications.Wo

A Novel Immunosuppressive Agent, Sirolimus, in the Treatment of Kaposi'S Sarcoma in a Renal Transplant Recipient

Renal transplant recipients are susceptible to Kaposi's sarcoma (KS) because of treatment with immunosuppressive drugs. Sirolimus, a new immunosuppressive agent, has been successfully used for immune-suppression in kidney transplant recipients. Several studies have shown the potential role of sirolimus to inhibit progression of KS in kidney-transplant recipients. This report details a kidney-transplant recipient with cutaneous KS who had a complete remission in response to sirolimus therapy.WoSScopu

Evaluation Of Sarcopenia In Renal Transplant Recipients

PubMedScopu